FDA initiative for diversity in cancer studies disappears : Shots
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration...
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration...